Literature DB >> 3132050

Is routine triple endoscopy cost-effective in head and neck cancer?

A Shaha1, E Hoover, J Marti, Y Krespi.   

Abstract

The multicentric occurrence of tumors of the upper aerodigestive tract has been well described, with an incidence ranging from 5 to 16 percent. Detection of a synchronous primary tumor at the time of initial work-up is crucial both for management and final outcome. However, there is a diversity of opinions regarding the extent of the work-up to search for a second primary tumor. Some investigators consider routine panendoscopy to be essential for every patient with a head and neck primary tumor. Routine esophagoscopy and bronchoscopy with bronchial washings in the absence of specific symptoms appear to have minimal benefit and high cost. In our study of 140 consecutive patients with primary squamous cell carcinoma of the head and neck seen over a period of 3 years, detailed history, thorough head and neck examination, routine chest radiograph, and barium swallow when indicated were sufficient to identify 18 patients (13 percent) with a second primary tumor in the upper aerodigestive tract. The synchronous tumors of eight patients were in the head and neck area, seven patients had carcinoma of the lung, and three patients had a second primary in the esophagus. Two patients had three synchronous primaries. Follow-up of these patients ranged from 1 to 4 years. Panendoscopy with cytologic washings was performed routinely. We questioned the cost-effectiveness of routine triscopy in every patient with head and neck cancer.

Entities:  

Mesh:

Year:  1988        PMID: 3132050     DOI: 10.1016/s0002-9610(88)80036-9

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  6 in total

Review 1.  [Responsibilities of the otorhinolaryngologist in the follow-up of malignancies of the head and neck].

Authors:  S Tesche; F U Metternich
Journal:  HNO       Date:  2006-09       Impact factor: 1.284

2.  Intraoperative endoscopy in obstructive hypopharyngeal carcinoma.

Authors:  Predrag Pesko; Milos Bjelovic; Predrag Sabljak; Dejan Stojakov; Ebrahimi Keramatollah; Dejan Velickovic; Bratislav Spica; Branka Nenadic; Aleksandra Djuric-Stefanovic; Djordjije Saranovic; Vera Todorovic
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

Review 3.  Second primary tumors in patients with head and neck cancer.

Authors:  Antonio Vitor Martins Priante; Emanuel Celice Castilho; Luiz Paulo Kowalski
Journal:  Curr Oncol Rep       Date:  2011-04       Impact factor: 5.075

4.  Diagnosis of second primary tumor and long-term survival after single initial triple endoscopy in patients with head and neck cancer.

Authors:  Antonio Vitor Martins Priante; Jefferson Luiz Gross; Claudia Zitron Sztokfisz; Inês Nobuko Nishimoto; Luiz Paulo Kowalski
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-18       Impact factor: 2.503

5.  Evidence for field change in oral cancer based on cytokeratin expression.

Authors:  G R Ogden; E B Lane; D V Hopwood; D M Chisholm
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

6.  The incidence and risk of developing a second primary esophageal cancer in patients with oral and pharyngeal carcinoma: a population-based study in Taiwan over a 25 year period.

Authors:  Kuan-Der Lee; Chang-Hsien Lu; Ping-Tsung Chen; Chunghuang Hubert Chan; Jen-Tsun Lin; Cih-En Huang; Chih-Cheng Chen; Min-Chi Chen
Journal:  BMC Cancer       Date:  2009-10-20       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.